Jiang, Y.,
Du, W.,
Chu, Q.,
Qin, Y.,
Tuguzbaeva, G.,
Wang, H.,
Li, A.,
Li, G.,
Li, Y.,
Chai, L.,
Yue, E.,
Sun, X.,
Wang, Z.,
V.N. Pavlov,
Yang, B.,
Bai, Y. (2018) Background/Aims: Arsenic trioxide (ATO) is a known anti-acute promyelocytic
leukemia (APL) reagent
Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа system cells. This is evidenced by the increased risk of
leukemia in patients with NF1 and the role of NF